BioCentury
ARTICLE | Company News

XTL acquires stake in iviGene

March 9, 2001 8:00 AM UTC

Infectious disease play XTL (LSE:XTL) acquired a 20 percent stake in iviGene (Alachua, Fla.) for $1 million and has an option to acquire the remaining 80 percent for $4 million in cash and $16 million...